Advertisement

BioDrugs

, Volume 8, Issue 1, pp 1–5 | Cite as

Prospects for T Cell Vaccination in Multiple Sclerosis

  • Robert Medaer
  • Piet Stinissen
  • Jingwu Zhang
  • Jef Raus
Leading Article
  • 9 Downloads

Summary

Accumulating evidence indicates that multiple sclerosis, a chronic inflammatory disease of the central nervous system, has an autoimmune origin. Since T cells reactive to myelin basic protein (MBP) are thought to play an important role in the pathogenesis of this disease, it was assumed that inactivation or depletion of this pathogenic T cell subset may have therapeutic effects in multiple sclerosis. We have recently reported that T cell vaccination, i.e. immunisation with attenuated autologous MBP-reactive T cell clones, leads to the depletion of the MBP-reactive T cells. Furthermore, this approach induced favourable clinical effects in the treated patients, encouraging further studies of T cell vaccination in multiple sclerosis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 1996. In pressGoogle Scholar
  2. 2.
    Hafler DA, Weiner HL. MS: a CNS and systemic autoimmune disease. Immunol Today 1989; 10: 104–7PubMedCrossRefGoogle Scholar
  3. 3.
    Zhang J, Markovic S, Lacet B, et al. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179: 973–84PubMedCrossRefGoogle Scholar
  4. 4.
    Wucherpfennig KW, Weiner HL, Hafler DA. T cell recognition of myelin basic protein. Immunol Today 1991; 12: 277PubMedCrossRefGoogle Scholar
  5. 5.
    Wucherpfennig KW, Zhang J, Witek C, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152: 5581–92PubMedGoogle Scholar
  6. 6.
    Vandevyver C, Mertens N, van den Elsen P, et al. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995; 25: 958–68PubMedCrossRefGoogle Scholar
  7. 7.
    Steinman L. The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol 1991; 49: 357–79PubMedCrossRefGoogle Scholar
  8. 8.
    Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990; 8: 579PubMedCrossRefGoogle Scholar
  9. 9.
    Ben-Nun A, Wekerle H, Cohen IR. Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 1981; 292: 60–1PubMedCrossRefGoogle Scholar
  10. 10.
    Lider O, Reshef T, Beraud E, et al. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988; 239: 181–3PubMedCrossRefGoogle Scholar
  11. 11.
    Vandenbark AA, Hashim GA, Offner H. Immunization with a synthetic T cell receptor V region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–4PubMedCrossRefGoogle Scholar
  12. 12.
    Sun D, Qin Y, Chluba J, et al. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T interactions. Nature 1988; 332: 437–53CrossRefGoogle Scholar
  13. 13.
    Zhang JW, Medaer R, Stinissen P, et al. MHC restricted clonotypic depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993; 261: 1451–4PubMedCrossRefGoogle Scholar
  14. 14.
    Zhang J, Vandevyver C, Stinissen P, et al. In vivo clonotypic regulation of human myelin basic protein reactive T cells by T cell vaccination. J Immunol 1995; 155: 5868–77PubMedGoogle Scholar
  15. 15.
    Medaer R, Stinissen P, Truyen L, et al. Depletion of myelin-basic protein autoreactive T cells by T cell vaccination: pilot trial in multiple sclerosis. Lancet 1995; 346: 807–8PubMedCrossRefGoogle Scholar
  16. 16.
    Stinissen P, Zhang J, Medaer R, et al. Vaccination with autoreactive T cell clones in multiple sclerosis: overview of immunological and clinical data. J Neurosci Res 1996; 45: 500–11PubMedCrossRefGoogle Scholar
  17. 17.
    Vandenbark AA, Hashim G, Offner H. TCR peptide therapy in autoimmune diseases. Int Rev Immunol 1993; 9: 251–76PubMedCrossRefGoogle Scholar
  18. 18.
    Lehman PV, Forsthuber T, Miller A, et al. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358: 155–7CrossRefGoogle Scholar
  19. 19.
    Salvetti M, Ristori G, D’Amato M, et al. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 1993; 23: 1232–9PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1997

Authors and Affiliations

  • Robert Medaer
    • 1
  • Piet Stinissen
    • 1
  • Jingwu Zhang
    • 1
  • Jef Raus
    • 1
  1. 1.Dr L Willems-Instituut and Limburgs Universitair CentrumDiepenbeekBelgium

Personalised recommendations